These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7848125)

  • 1. Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors.
    Chamberlain MC; Barba D; Kormanik P; Berson AM; Saunders WM; Shea MC
    Arch Neurol; 1995 Feb; 52(2):162-7. PubMed ID: 7848125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent carboplatin and iodine-125 brachytherapy for recurrent glioblastoma multiforme.
    Chamberlain M; Kormanik P; Barba D; Saunders W; Fuller B; Shea W; Smith D
    Int J Oncol; 1997 Jul; 11(1):199-205. PubMed ID: 21528202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
    VanderSpek L; Fisher B; Bauman G; Macdonald D
    Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources.
    Gutin PH; Phillips TL; Wara WM; Leibel SA; Hosobuchi Y; Levin VA; Weaver KA; Lamb S
    J Neurosurg; 1984 Jan; 60(1):61-8. PubMed ID: 6358430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources.
    Gutin PH; Leibel SA; Wara WM; Choucair A; Levin VA; Philips TL; Silver P; Da Silva V; Edwards MS; Davis RL
    J Neurosurg; 1987 Dec; 67(6):864-73. PubMed ID: 3316532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2.
    Gutin PH; Prados MD; Phillips TL; Wara WM; Larson DA; Leibel SA; Sneed PK; Levin VA; Weaver KA; Silver P
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):601-6. PubMed ID: 1651302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas.
    Leibel SA; Gutin PH; Wara WM; Silver PS; Larson DA; Edwards MS; Lamb SA; Ham B; Weaver KA; Barnett C
    Int J Radiat Oncol Biol Phys; 1989 Dec; 17(6):1129-39. PubMed ID: 2557303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotaxic interstitial irradiation of malignant brain tumors.
    Gutin PH; Leibel SA
    Neurol Clin; 1985 Nov; 3(4):883-93. PubMed ID: 3001493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Volumetric changes following 125I interstitial brachytherapy of gliomas].
    Julow J; Viola A; Major T; Mangel L; Bajzik G; Repa I; Sági S; Valálik I; Emri M; Trón L; Németh G
    Ideggyogy Sz; 2005 Mar; 58(3-4):120-32. PubMed ID: 15887415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial radiation in recurrent malignant gliomas.
    Hitchon PW; Jani SK; VanGilder JC; Godersky JC; Doornbos S
    Appl Neurophysiol; 1987; 50(1-6):292-4. PubMed ID: 3329866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial.
    Tatter SB; Shaw EG; Rosenblum ML; Karvelis KC; Kleinberg L; Weingart J; Olson JJ; Crocker IR; Brem S; Pearlman JL; Fisher JD; Carson K; Grossman SA;
    J Neurosurg; 2003 Aug; 99(2):297-303. PubMed ID: 12924704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High activity iodine-125 interstitial implant for gliomas.
    Scharfen CO; Sneed PK; Wara WM; Larson DA; Phillips TL; Prados MD; Weaver KA; Malec M; Acord P; Lamborn KR
    Int J Radiat Oncol Biol Phys; 1992; 24(4):583-91. PubMed ID: 1429079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.
    Reardon DA; Akabani G; Coleman RE; Friedman AH; Friedman HS; Herndon JE; McLendon RE; Pegram CN; Provenzale JM; Quinn JA; Rich JN; Vredenburgh JJ; Desjardins A; Gururangan S; Badruddoja M; Dowell JM; Wong TZ; Zhao XG; Zalutsky MR; Bigner DD
    J Clin Oncol; 2006 Jan; 24(1):115-22. PubMed ID: 16382120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interstitial iodine 125 and concomitant cisplatin followed by hyperfractionated external beam irradiation for malignant supratentorial glioma. Preliminary experience at the University of Tennessee, Memphis.
    Fontanesi J; Clark WC; Weir A; Barry A; Kumar P; Miller A; Eddy T; Tai D; Kun LE
    Am J Clin Oncol; 1993 Oct; 16(5):412-7. PubMed ID: 8213624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanent iodine-125 interstitial radiation therapy in the treatment of non-glioblastoma multiforme high-grade gliomas.
    Zamorano L; Li Q; Tekyi-Mensah S; Gaspar L; Fontanesi J; Levin K
    Stereotact Funct Neurosurg; 2003; 81(1-4):10-7. PubMed ID: 14742958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B; Grujicic D; Antunovic V; Djuric L; Stojanovic M; Shibamoto Y
    Int J Radiat Oncol Biol Phys; 1994 Dec; 30(5):1179-85. PubMed ID: 7961028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme.
    Larson DA; Suplica JM; Chang SM; Lamborn KR; McDermott MW; Sneed PK; Prados MD; Wara WM; Nicholas MK; Berger MS
    Neuro Oncol; 2004 Apr; 6(2):119-26. PubMed ID: 15134626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interstitial brachytherapy in malignant gliomas].
    Hoshino T
    Gan No Rinsho; 1989 Sep; 35(11):1355-61. PubMed ID: 2681874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent iodine-125 implants in the up-front treatment of malignant gliomas.
    Fernandez PM; Zamorano L; Yakar D; Gaspar L; Warmelink C
    Neurosurgery; 1995 Mar; 36(3):467-73. PubMed ID: 7753345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.